More than just a T-box: The role of T-bet as a possible biomarker and therapeutic target in autoimmune diseases

Immunotherapy

Volumn 3, Issue 3, 2011, Pages 435-441

  Ji, Niannian ^a   Sosa, Rebecca A ^a   Forsthuber, Thomas G ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

autoimmune disease; autoreactive CD4+ T cell; IFN ; T bet; Th1 cell

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; CYTOKINE RECEPTOR; IMMUNOLOGIC AGENT; T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR T BET;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; CYTOKINE PRODUCTION; DRUG TARGETING; HUMAN; IMMUNOTHERAPY; LYMPHOCYTE DIFFERENTIATION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TH1 CELL;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; INTERFERON-GAMMA; MICE; MODELS, ANIMAL; MULTIPLE SCLEROSIS; RECEPTORS, CYTOKINE; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTE SUBSETS; TH1 CELLS;

EID: 79952681375     PISSN: 1750743X     EISSN: None     Source Type: Journal    
DOI: 10.2217/imt.10.111     Document Type: Review

References (74)

1. Commins SP, Borish L, Steinke JW: Immunologic messenger molecules: cytokines, interferons, and chemokines. J. Allergy Clin. Immunol. 125, S53-S72 (2010).
2. Kunz M, Ibrahim SM: Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inflamm. Abstract 979258 (2009).
3. O'Garra A: Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8, 275-283 (1998).
4. Axtell RC, de Jong BA, Boniface K et al.: T helper Type 1 and 17 cells determine efficacy of interferon-b in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 16, 406-412 (2010).
5. Chu CQ, Wittmer S, Dalton DK: Failure to suppress the expansion of the activated CD4 T cell population in interferon g-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192, 123-128 (2000). (Pubitemid 30470813)
6. Das J, Ren GW, Zhang LY et al.: Transforming growth factor b is dispensable for the molecular orchestration of Th17 cell differentiation. J. Exp. Med. 206, 2407-2416 (2009).
7. Kleinschek MA, Owyang AM, Joyce-Shaikh B et al.: IL-25 regulates Th17 function in autoimmune inflammation. J. Exp. Med. 204, 161-170 (2007). (Pubitemid 46148766)
8. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC: A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203, 1685-1691 (2006). (Pubitemid 44036274)
9. Yang XX O, Chang SH, Park H et al.: Regulation of inflammatory responses by IL-17F. J. Exp. Med. 205, 1063-1075 (2008). (Pubitemid 351679682)
10. Bettelli E, Sullivan B, Szabo SJ, Sobel RA, Glimcher H, Kuchroo VK: Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J. Exp. Med. 200, 79-87 (2004). (Pubitemid 38924730)
11. Djuretic IM, Levanon D, Negreanu V, Groner Y, Rao A, Ansel KM: Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper Type 1 cells. Nat. Immunol. 8, 145-153 (2007). (Pubitemid 46152645)
12. Frisullo G, Angelucci F, Caggiula M et al.: pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J. Neurosci. Res. 84, 1027-1036 (2006). (Pubitemid 44521047)
13. Neurath MF, Weigmann B, Finotto S et al.: The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195, 1129-1143 (2002). (Pubitemid 34517139)
14. Szabo SJ, Kim ST, Costa GL, Zhang XK, Fathman CG, Glimcher LH: A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655-669 (2000).
15. Yang YH, Weiner J, Liu Y et al.: T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J. Exp. Med. 206, 1549-1564 (2009).
16. Zhuang YH, Huang Z, Nishida J, Brown M, Zhang L, Huang H: A continuous T-bet expression is required to silence the interleukin-4-producing potential in T helper type 1 cells. Immunology 128, 34-42 (2009).
17. Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH: Distinct effects of T-bet in Th1 lineage commitment and IFN-g production in CD4 and CD8 T cells. Science 295, 338-342 (2002). (Pubitemid 34074366)
18. Mullen AC, High FA, Hutchins AS et al.: Role of T-bet in commitment of Th1 cells before IL-12-dependent selection. Science 292, 1907-1910 (2001). (Pubitemid 32538365)
19. Tong YK, Aune T, Boothby M: T-bet antagonizes mSin3a recruitment and transactivates a fully methylated IFN-g promoter via a conserved T-box half-site. Proc. Natl Acad. Sci. USA 102, 2034-2039 (2005). (Pubitemid 40262007)
20. Chang SJ, Collins PL, Aune TM: T-bet dependent removal of Sin3A-histone deacetylase complexes at the Ifng locus drives Th1 differentiation. J. Immunol. 181, 8372-8381 (2008).
21. Lighvani AA, Frucht DM, Jankovic D et al.: T-bet is rapidly induced by interferon-g in lymphoid and myeloid cells. Proc. Natl Acad. Sci. USA 98, 15137-15142 (2001). (Pubitemid 34013982)
22. Afkarian M, Sedy JR, Yang J et al.: T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat. Immunol. 3, 549 (2002).
23. Thieu VT, Yu Q, Chang HC et al.: Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination. Immunity 29, 679-690 (2008).
24. Hwang ES, Szabo SJ, Schwartzberg PL, Glimcher LH: T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307, 430-433 (2005). (Pubitemid 40139989)
25. Usui T, Preiss JC, Kanno Y et al.: T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription. J. Exp. Med. 203, 755-766 (2006).
26. Hwang ES, Hong JH, Glimcher LH: IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508. J. Exp. Med. 202, 1289-1300 (2005). (Pubitemid 41586959)
27. Matsuda JL, George TC, Hagman J, Gapin L: Temporal dissection of T-bet functions. J. Immunol. 178, 3457-3465 (2007). (Pubitemid 46417610)
28. Underhill GH, Zisoulis DG, Kolli KP, Ellies LG, Marth JD, Kansas GS: A crucial role for T-bet in selectin ligand expression in T helper 1 (Th1) cells. Blood 106, 3867-3873 (2005). (Pubitemid 41739025)
29. Lord GM, Rao RM, Choe H et al.: T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood 106, 3432-3439 (2005). (Pubitemid 41609178)
30. Anderson AC, Lord GM, Dardalhon V et al.: T-bet, a Th1 transcription factor regulates the expression of Tim-3. Eur. J. Immunol. 40, 859-866 (2010).
31. Cruz-Guilloty F, Pipkin ME, Djuretic IM et al.: Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J. Exp. Med. 206, 51-59 (2009).
32. Intlekofer AM, Takemoto N, Wherry EJ et al.: Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6, 1236-1244 (2005). (Pubitemid 43045635)
33. Joshi NS, Cui W, Chandele A et al.: Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281-295 (2007). (Pubitemid 47284924)
34. Sullivan BM, Juedes A, Szabo SJ, von Herrath M, Glimcher LH: Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl Acad. Sci. USA 100, 15818-15823 (2003). (Pubitemid 38021073)
35. Lugo-Villarino G, Maldonado-Lopez R, Possemato R, Penaranda C, Glimcher LH: T-bet is required for optimal production of IFN-g and antigen-specific T cell activation by dendritic cells. Proc. Natl Acad. Sci. USA 100, 7749-7754 (2003). (Pubitemid 36760041)
36. Peng SL, Szabo SJ, Glimcher LH: T-bet regulates IgG class switching and pathogenic autoantibody production. Proc. Natl Acad. Sci. USA 99, 5545-5550 (2002). (Pubitemid 34411585)
37. Gerth AJ, Lin L, Peng SL: T-bet regulates T-independent IgG2a class switching. Int. Immunol. 15, 937-944 (2003). (Pubitemid 36987291)
38. Townsend MJ, Weinmann AS, Matsuda JL et al.: T-bet regulates the terminal maturation and homeostasis of NK and Va14i NKT cells. Immunity 20, 477-494 (2004). (Pubitemid 38482125)
39. Robbins SH, Tessmer MS, Van Kaer L, Brossay L: Direct effects of T-bet and MHC class I expression, but not STAT1, on peripheral NK cell maturation. Eur. J. Immunol. 35, 757-765 (2005). (Pubitemid 40425531)
40. Jenne CN, Enders A, Rivera R et al.: T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J. Exp. Med. 206, 2469-2481 (2009).
41. Matsuoka K, Inoue N, Sato T et al.: T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease. Gut 53, 1303-1308 (2004). (Pubitemid 39120117)
42. Juedes AE, Rodrigo E, Togher L, Glimcher LH, von Herrath MG: T-bet controls autoaggressive CD8 lymphocyte responses in Type I diabetes. J. Exp. Med. 199, 1153-1162 (2004). (Pubitemid 38619911)
43. Liu RL, Hao JW, Dayao CS, Shi FD, Campagnolo DI: T-bet deficiency decreases susceptibility to experimental myasthenia gravis. Exp. Neurol. 220, 366-373 (2009).
44. Wang JS, Fathman JW, Lugo-Villarino G et al.: Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells. J. Clin. Invest. 116, 414-421 (2006). (Pubitemid 43228358)
45. Rangachari M, Mauermann N, Marty RR et al.: T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J. Exp. Med. 203, 2009-2019 (2006). (Pubitemid 44188474)
46. Ferber IA, Brocke S, TaylorEdwards C et al.: Mice with a disrupted IFN-g gene are susceptible to the induction of experimental autoimmune encephalolmyelitis (EAE). J. Immunol. 156, 5-7 (1996).
47. Haak S, Croxford AL, Kreymborg K et al.: IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 119, 61-69 (2009).
48. Heremans H, Dillen C, Groenen M, Martens E, Billiau A: Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-g. Eur. J. Immunol. 26, 2393-2398 (1996). (Pubitemid 26340941)
49. Komiyama Y, Nakae S, Matsuki T et al.: IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177, 566-573 (2006). (Pubitemid 43939170)
50. Voskuhl RR, Martin R, Bergman C, Dalal M, Ruddle NH, Mcfarland HF: T-helper-1 (Th1) functional phenotype of human myelin basic protein-specific T-lymphocytes. Autoimmunity 15, 137-143 (1993). (Pubitemid 23276008)
51. Willenborg DO, Fordham S, Bernard CC, Cowden WB, Ramshaw IA: IFN-g plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157, 3223-4227 (1996).
52. Lublin FD, Knobler RL, Kalman B et al.: Monoclonal anti-g interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity 16, 267-274 (1993). (Pubitemid 24111624)
53. Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM: IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 205, 1535-1541 (2008). (Pubitemid 351962016)
54. Sutton C, Brereton C, Keogh B, Mills KHG, Lavelle EC: A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203, 1685-1691 (2006). (Pubitemid 44036274)
55. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B: TGFb in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17- producing T cells. Immunity 24, 179-189 (2006). (Pubitemid 43214587)
56. Lovett-Racke AE, Rocchini AE, Choy J et al.: Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes. Immunity 21, 719-731 (2004). (Pubitemid 39487893)
57. Gocke AR, Cravens PD, Ben LH et al.: T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity. J. Immunol. 178, 1341-1348 (2007). (Pubitemid 46154603)
58. Nath N, Prasad R, Giri S, Singh AK, Singh I: T-bet is essential for the progression of experimental autoimmune encephalomyelitis. Immunology 118, 384-391 (2006).
59. Sasaki Y, Ihara K, Matsuura N et al.: Identification of a novel Type 1 diabetes susceptibility gene, T-bet. Hum. Genet. 115, 177-184 (2004). (Pubitemid 39162197)
60. Akahoshi M, Obara K, Hirota T et al.: Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma. Hum. Genet. 117, 16-26 (2005). (Pubitemid 40778778)
61. Raby BA, Hwang ES, Van Steen K et al.: T-bet polymorphisms are associated with asthma and airway hyperresponsiveness. Am. J. Resp. Crit. Care Med. 173, 64-70 (2006). (Pubitemid 43069789)
62. Tantisira KG, Hwang ES, Raby BA et al.: TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proc. Natl Acad. Sci. USA 101, 18099-180104 (2004).
63. Coughlin SS, Szklo M, Baughman K, Pearson TA: Idiopathic dilated cardiomyopathy and atopic disease - epidemiologic evidence for an association with asthma. Am. Heart J. 118, 768-774 (1989). (Pubitemid 19242574)
64. Sengstock DM, Obeidat O, Pasnoori V, Mehra P, Sandberg KR, McCullough PA: Asthma, b-agonists, and development of congestive heart failure: results of the ABCHF study. J. Card. Fail. 8, 232-238 (2002).
65. Chan RW Y, Lai FM, Li EK M et al.: Expression of T-bet, a Type 1 T-helper cell transcription factor, in the urinary sediment of lupus patients predicts disease flare. Rheumatology 46, 44-48 (2007). (Pubitemid 44932782)
66. Iorio R, Frisullo G, Nociti V et al.: T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. Clin. Immunol. 131, 70-83 (2009).
67. Drulovic J, Savic E, Pekmezovic T et al.: Expression of Th1 and Th17 cytokines and transcription factors in multiple sclerosis patients: does baseline T-bet mRNA predict the response to interferon-b treatment? J. Neuroimmunol. 215, 90-95 (2009).
68. Frisullo G, Nociti V, Lorio R et al.: Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. Clin. Immunol. 124, 284-293 (2007). (Pubitemid 47247610)
69. Liberman AC, Refojo D, Druker J et al.: The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction. FASEB J. 21, 1177-1188 (2007). (Pubitemid 46495707)
70. Wong BL, Zhu SL, Huang XR et al.: Essential role for macrophage migration inhibitory factor in gastritis induced by Helicobacter pylori. Am. J. Pathol. 174, 1319-1328 (2009).
71. Ni J, Shu YY, Zhu YN et al.: COX-2 inhibitors ameliorate experimental autoimmune encephalomyelitis through modulating IFN-g and IL-10 production by inhibiting T-bet expression. J. Neuroimmunol. 186, 94-103 (2007). (Pubitemid 46770867)
72. Yu JH, Wei M, Boyd Z et al.: Transcriptional control of human T-bet expression: the role of Sp1. Eur. J. Immunol. 37, 2549-2561 (2007). (Pubitemid 47423624)
73. Shin HJ, Lee JB, Park SH, Chang J, Lee CW: T-bet expression is regulated by EGR1- mediated signaling in activated T cells. Clin. Immunol. 131, 385-394 (2009).
74. Buono C, Binder CJ, Stavrakis G, Witztum JL, Glimcher LH, Lichtman AH: T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc. Natl Acad. Sci. USA 102, 1596-1601 (2005). (Pubitemid 40209213)